Fluticasone furoate, umeclidinium, vilanterol 100/62.5/25mcg, 200/62.5/25mcg; per inh; dry pwd for oral inhalation. Trelegy Ellipta is supplied as a disposable light grey and beige plastic inhaler ...

Announcement of the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final ...

GlaxoSmithKline won approval for a three-drug COPD inhaler, Trelegy Ellipta, in 2017. 3D medical animation services have emerged as a groundbreaking tool in the healthcare industry ...

The FDA has approved GlaxoSmithKline’s Trelegy Ellipta inhaler for asthma in adults, adding to its existing use in chronic obstructive pulmonary disease (COPD), stealing a march on rivals ...

Trelegy is a key drug for GSK, and analysts predict peak sales in excess of $1billion. The company needs new revenues in respiratory diseases, as its ageing blockbuster inhaler Advair will face ...